SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.35%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$293M
AUM Growth
+$293M
(+7.2%)
Cap. Flow
+$5.45M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
28.19%
Holding
93
New
21
Increased
25
Reduced
19
Closed
18
Top Buys
| 1 |
Danaher
DHR
|
$4.72M |
| 2 |
Zoetis
ZTS
|
$4.14M |
| 3 |
Thermo Fisher Scientific
TMO
|
$3.78M |
| 4 |
AbbVie
ABBV
|
$3.11M |
| 5 |
Zimmer Biomet
ZBH
|
$2.93M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$9.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.01M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$4.91M |
| 4 |
Merck
MRK
|
$4.81M |
| 5 |
Cardinal Health
CAH
|
$3.9M |
Sector Composition
| 1 | Healthcare | 87% |
| 2 | Financials | 2.99% |
| 3 | Energy | 1.23% |
| 4 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bio-Rad Laboratories Class A
BIO
$8.06B
| $2.22M | 0.76% |
+10,000
| New | +$2.22M |
|
52
Perrigo
PRGO
$3.27B
| $2.12M | 0.72% |
25,000
-20,000
| -44% | -$1.69M |
|
53
Labcorp
LH
$23.1B
| $2.1M | 0.71% |
+13,900
| New | +$2.1M |
|
54
Dentsply Sirona
XRAY
$2.85B
| $2.09M | 0.71% |
+35,000
| New | +$2.09M |
|
55
Mettler-Toledo International
MTD
$26.8B
| $2M | 0.68% |
+3,200
| New | +$2M |
|
|
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
| $1.9M | 0.65% |
+30,000
| New | +$1.9M |
|
57
Qiagen
QGEN
$10.1B
| $1.89M | 0.64% |
+60,000
| New | +$1.89M |
|
58
Quest Diagnostics
DGX
$20.3B
| $1.87M | 0.64% |
+20,000
| New | +$1.87M |
|
59
Neurocrine Biosciences
NBIX
$13.8B
| $1.84M | 0.63% |
30,000
+10,000
| +50% | +$613K |
|
60
Dr. Reddy's Laboratories
RDY
$11.8B
| $1.78M | 0.61% |
+50,000
| New | +$1.78M |
|
61
Teva Pharmaceuticals
TEVA
$21.1B
| $1.76M | 0.6% |
+100,000
| New | +$1.76M |
|
|
CTLT
62
DELISTED
CATALENT, INC.
CTLT
| $1.65M | 0.56% |
+41,400
| New | +$1.65M |
|
|
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.63M | 0.56% |
30,000
+5,000
| +20% | +$272K |
|
|
ATHN
64
DELISTED
Athenahealth, Inc.
ATHN
| $1.49M | 0.51% |
+12,000
| New | +$1.49M |
|
65
Bruker
BRKR
$5.16B
| $1.49M | 0.51% |
+50,000
| New | +$1.49M |
|
|
KITE
66
DELISTED
Kite Pharma, Inc.
KITE
| $1.44M | 0.49% |
8,000
-10,000
| -56% | -$1.8M |
|
|
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.35M | 0.46% |
25,000
-5,000
| -17% | -$270K |
|
|
CBM
68
DELISTED
Cambrex Corporation
CBM
| $1.32M | 0.45% |
+24,039
| New | +$1.32M |
|
|
TSRO
69
DELISTED
TESARO, Inc.
TSRO
| $1.29M | 0.44% |
10,000
-5,000
| -33% | -$646K |
|
|
KND
70
DELISTED
Kindred Healthcare
KND
| $177K | 0.06% |
25,963
-99,037
| -79% | -$675K |
|
71
Acadia Healthcare
ACHC
$2.12B
| – | – |
-50,000
| Closed | -$2.47M |
|
72
Assertio
ASRT
$80.4M
| – | – |
-180,000
| Closed | -$1.93M |
|
73
Bristol-Myers Squibb
BMY
$96B
| – | – |
0
| – | – |
|
|
74
Cardinal Health
CAH
$35.5B
| – | – |
-50,000
| Closed | -$3.9M |
|
75
Community Health Systems
CYH
$387M
| – | – |
-220,000
| Closed | -$2.19M |
|